Gustavo C. Rodriguez
Northwestern University(US)NorthShore University HealthSystem(US)University of Chicago(US)Evanston Hospital(US)Celsius Therapeutics (United States)(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, Estrogen and related hormone effects, Vitamin D Research Studies
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial(2021)399 cited
- → A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population(2010)341 cited
- → Ovarian Cancer(2012)328 cited
- → Identification of six new susceptibility loci for invasive epithelial ovarian cancer(2015)259 cited
- → Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer